CCL3 and breast carcinoma: The above results demonstrated that subsets 1 and 2 might be the transition stage from M1 to M2, which was consistent with the results reported by Azizi et al. who found that some TAM cell groups in breast cancer highly expressed both the M1 (such as CCL3) and M2 (such as MARCO and NRP2) characteristic genes.